Penicillium marneffei infection in HIV

Current Opinion in Infectious Diseases

Volumn 21, Issue 1, 2008, Pages 31-36

  Ustianowski, Andrew P ^a   Sieu, Tran P M ^b   Day, Jeremy N ^a,c  

^a NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

Author keywords

AIDS; HIV; Penicilliosis; Penicillium marneffei

Indexed keywords

AMPHOTERICIN B; COTRIMOXAZOLE; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; PLACEBO; TERBINAFINE; VORICONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BACTERIAL INFECTION; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG WITHDRAWAL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONOTHERAPY; PANDEMIC; PENICILLIOSIS; PENICILLIUM MARNEFFEI; PNEUMOCYSTOSIS; PROPHYLAXIS; REVIEW;

EID: 38149095049     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/QCO.0b013e3282f406ae     Document Type: Review

References (51)

1. Fisher MC, Aanensen D, de Hoog S, Vanittanakom N. Multilocus microsatellite typing system for Penicillium marneffei reveals spatially structured populations. J Clin Microbiol 2004; 42:5065-5069.
2. Antinori S, Gianelli E, Bonaccorso C, et al. Disseminated Penicillium marneffei infection in an HIV-positive Italian patient and a review of cases reported outside endemic regions. J Travel Med 2006; 13:181-188.
3. Vilar FJ, Hunt R, Wilkins EG, et al. Disseminated Penicillium marneffei in a patient infected with human immunodeficiency virus. Int J STD AIDS 2000; 11:126-128.
4. Ajello L, Padhye AA, Sukroongreung S, et al. Occurrence of Penicillium marneffei infections among wild bamboo rats in Thailand. Mycopathologia 1995; 131:1-8.
5. Chariyalertsak S, Vanittanakom P, Nelson KE, et al. Rhizomys sumatrensis and Cannomys badius, new natural animal hosts of Penicillium marneffei. J Med Vet Mycol 1996; 34:105-110.
6. Deng ZL, Yun M, Ajello L. Human penicilliosis marneffei and its relation to the bamboo rat (Rhizomys pruinosus). J Med Vet Mycol 1986; 24:383-389.
7. Gugnani H, Fisher MC, Paliwal-Johsi A, et al. Role of Cannomys badius as a natural animal host of Penicillium marneffei in India. J Clin Microbiol 2004; 42:5070-5075.
8. Chariyalertsak S, Sirisanthana T, Supparatpinyo K, Nelson KE. Seasonal variation of disseminated Penicillium marneffei infections in northern Thailand: a clue to the reservoir? J Infect Dis 1996; 173:1490-1493.
9. Chariyalertsak S, Sirisanthana T, Supparatpinyo K, et al. Case-control study of risk factors for Penicillium marneffei infection in human immunodeficiency virus-infected patients in northern Thailand. Clin Infect Dis 1997; 24:1080-1086.
10. Lo Y, Tintelnot K, Lippert U, Hoppe T. Disseminated Penicillium marneffei infection in an African AIDS patient. Trans R Soc Trop Med Hyg 2000; 94:187.
11. Supparatpinyo K, Khamwan C, Baosoung V, et al. Disseminated Penicillium marneffei infection in southeast Asia. Lancet 1994; 344:110-113.
12. Wong KH, Lee SS. Comparing the first and second hundred AIDS cases in Hong Kong. Singapore Med J 1998; 39:236-240.
13. Clezy K, Sirisanthana T, Sirisanthana V, et al. Late manifestations of HIV in Asia and the Pacific. AIDS 1994; 8 (Suppl 2):S35-S43.
14. Wong SS, Ho TY, Ngan AH, et al. Biotyping of Penicillium marneffei reveals concentration-dependent growth inhibition by galactose. J Clin Microbiol 2001; 39:1416-1421.
15. Youngchim S, Vanittanakom N, Hamilton AJ. Analysis of the enzymatic activity of mycelial and yeast phases of Penicillium marneffei. Med Mycol 1999; 37:445-450.
16. Baca OG, Roman MJ, Glew RH, et al. Acid phosphatase activity in Coxiella burnetii: a possible virulence factor. Infect Immun 1993; 61:4232-4239.
17. Reilly TJ, Baron GS, Nano FE, Kuhlenschmidt MS. Characterization and sequencing of a respiratory burst-inhibiting acid phosphatase from Francisella tularensis. J Biol Chem 1996; 271:10973-10983.
18. Capponi M, Segretain G, Sureau P. Penicillosis from Rhizomys sinensis. Bull Soc Pathol Exot Filiales 1956; 49:418-421.
19. Segretain G. Penicillium marneffei n.sp., agent of a mycosis of the reticuloendothelial system. Mycopathologia 1959; 11:327-353.
20. DiSalvo AF, Fickling AM, Ajello L. Infection caused by Penicillium marneffei: description of first natural infection in man. Am J Clin Pathol 1973; 60:259-263.
21. Chiewchanvit S, Mahanupab P, Hirunsri P, Vanittanakom N. Cutaneous manifestations of disseminated Penicillium marneffei mycosis in five HIV-infected patients. Mycoses 1991; 34:245-249.
22. Deng Z, Ribas JL, Gibson DW, Connor DH. Infections caused by Penicillium marneffei in China and Southeast Asia: review of eighteen published cases and report of four more Chinese cases. Rev Infect Dis 1988; 10:640-652.
23. Duong TA. Infection due to Penicillium marneffei, an emerging pathogen: review of 155 reported cases. Clin Infect Dis 1996; 23:125-130.
24. Hung CC, Hsueh PR, Chen MY, et al. Invasive infection caused by Penicillium marneffei: an emerging pathogen in Taiwan. Clin Infect Dis1998; 26:202-203.
25. Kurup A, Leo YS, Tan AL, Wong SY. Disseminated Penicillium marneffei infection: a report of five cases in Singapore. Ann Acad Med Singapore 1999; 28:605-609.
26. Ranjana KH, Priyokumar K, Singh TJ, et al. Disseminated Penicillium marneffei infection among HIV-infected patients in Manipur state, India. J Infect 2002; 45:268-271.
27. Sirisanthana T, Supparatpinyo K. Epidemiology and management of penicilliosis in human immunodeficiency virus-infected patients. Int J Infect Dis 1998; 3:48-53.
28. Sirisanthana V, Sirisanthana T. Penicillium marneffei infection in children infected with human immunodeficiency virus. Pediatr Infect Dis J 1993; 12:1021-1025.
29. Sirisanthana V, Sirisanthana T. Disseminated Penicillium marneffei infection in human immunodeficiency virus-infected children. Pediatr Infect Dis J 1995; 14:935-940.
30. Deesomchok A, Tanprawate S. A 12-case series of Penicillium marneffei pneumonia. J Med Assoc Thai 2006; 89:441-447.
31. Vanittanakom N, Sirisanthana T. Penicillium marneffei infection in patients infected with human immunodeficiency virus. Curr Top Med Mycol 1997; 8:35-42.
32. Chaiwun B, Khunamornpong S, Sirivanichai C, et al. Lymphadenopathy due to Penicillium marneffei infection: diagnosis by fine needle aspiration cytology. Mod Pathol 2002; 15:939-943.
33. Mootsikapun P, Srikulbutr S. Histoplasmosis and penicilliosis: comparison of clinical features, laboratory findings and outcome. Int J Infect Dis 2006; 10:66-71.
34. Sun HY, Chen MY, Hsiao CF, et al. Endemic fungal infections caused by Cryptococcus neoformans and Penicillium marneffei in patients infected with human immunodeficiency virus and treated with highly active antiretroviral therapy. Clin Microbiol Infect 2006; 12:381-388.
35. Kaufman L, Standard PG, Anderson SA, et al. Development of specific fluorescent-antibody test for tissue form of Penicillium marneffei. J Clin Microbiol 1995; 33:2136-2138.
36. Trewatcharegon S, Chaiyaroj SC, Chongtrakool P, Sirisinha S. Production and characterization of monoclonal antibodies reactive with the mycelial and yeast phases of Penicillium marneffei. Med Mycol 2000; 38:91-96.
37. Vanittanakom N, Cooper CR Jr, Fisher MC, Sirisanthana T. Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects. Clin Microbiol Rev 2006; 19:95-110. This paper provides an excellent review of the epidemiology and present state of diagnostics for P. marneffei.
38. Huang YT, Hung CC, Liao CH, et al. Detection of circulating galactomannan in serum samples for diagnosis of Penicillium marneffei infection and cryptococcosis among patients infected with human immunodeficiency virus. J Clin Microbiol 2007; 45:2858-2862. This paper illustrates the exciting potential for a commercially available Aspergillus galactomannan assay to assist in the diagnosis of penicilliosis.
39. Imwidthaya P, Thipsuvan K, Chaiprasert A, et al. Penicillium marneffei: types and drug susceptibility. Mycopathologia 2001; 149:109-115.
40. Radford SA, Johnson EM, Warnock DW. In vitro studies of activity of voriconazole (UK-109,496), a new triazole antifungal agent, against emerging and less-common mold pathogens. Antimicrob Agents Chemother 1997; 41:841-843.
41. Ryder NS. Activity of terbinafine against serious fungal pathogens. Mycoses 1999; 42 (Suppl 2):115-119.
42. Sar B, Boy S, Keo C, et al. In vitro antifungal-drug susceptibilities of mycelial and yeast forms of Penicillium marneffei isolates in Cambodia. J Clin Microbiol 2006; 44:4208-4210.
43. Nakai T, Uno J, Ikeda F, et al. In vitro antifungal activity of Micafungin (FK463) against dimorphic fungi: comparison of yeast-like and mycelial forms. Antimicrob Agents Chemother 2003; 47:1376-1381.
44. Supparatpinyo K, Nelson KE, Merz WG, et al. Response to antifungal therapy by human immunodeficiency virus-infected patients with disseminated Penicillium marneffei infections and in vitro susceptibilities of isolates from clinical specimens. Antimicrob Agents Chemother 1993; 37:2407-2411.
45. Sirisanthana T, Supparatpinyo K, Perriens J, Nelson KE. Amphotericin B and itraconazole for treatment of disseminated Penicillium marneffei infection in human immunodeficiency virus-infected patients. Clin Infect Dis 1998; 26:1107-1110.
46. Supparatpinyo K, Chiewchanvit S, Hirunsri P, et al. An efficacy study of itraconazole in the treatment of Penicillium marneffei infection. J Med Assoc Thai 1992; 75:688-691.
47. Supparatpinyo K, Schlamm HT. Voriconazole as therapy for systemic Penicillium marneffei infections in AIDS patients. Am J Trop Med Hyg 2007; 77:350-353. This paper investigates the potential of voriconazole and, although few patients were studied, it describes some promising early results.
48. Supparatpinyo K, Perriens J, Nelson KE, Sirisanthana T. A controlled trial of itraconazole to prevent relapse of Penicillium marneffei infection in patients infected with the human immunodeficiency virus. N Engl J Med 1998; 339:1739-1743.
49. + lymphocyte count above 100/μl for more than 6 months may be adequate.
50. Hung CC, Chen MY, Hsieh SM, et al. Discontinuation of secondary prophylaxis for penicilliosis marneffei in AIDS patients responding to highly active antiretroviral therapy. AIDS 2002; 16:672-673.
51. Chariyalertsak S, Supparatpinyo K, Sirisanthana T, Nelson KE. A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand. Clin Infect Dis 2002; 34:277-284.